Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 2
2008 1
2009 1
2010 1
2012 1
2013 2
2014 2
2017 1
2020 1
2021 1
2022 1
2023 2
2024 5
2025 4
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Østergaard M, van Vollenhoven RF, Rudin A, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Gudbjornsson B, Ørnbjerg LM, Bøyesen P, Lend K, Hørslev-Petersen K, Uhlig T, Sokka T, Grondal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic MC, Aga AB, Faustini F, Parmanne P, Lorenzen T, Giovanni C, Back J, Hendricks O, Vedder D, Rannio T, Grenholm E, Ljoså MK, Brodin E, Lindegaard H, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Bay Laurbjerg T, Bakland G, Olsen IC, Haavardsholm EA, Lampa J; NORD-STAR study group. Østergaard M, et al. Among authors: heiberg ms. Ann Rheum Dis. 2023 Oct;82(10):1286-1295. doi: 10.1136/ard-2023-224116. Epub 2023 Jul 9. Ann Rheum Dis. 2023. PMID: 37423647 Free article. Clinical Trial.
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial.
Hetland ML, Haavardsholm EA, Rudin A, Nordström D, Nurmohamed M, Gudbjornsson B, Lampa J, Hørslev-Petersen K, Uhlig T, Grondal G, Østergaard M, Heiberg MS, Twisk J, Lend K, Krabbe S, Hyldstrup LH, Lindqvist J, Hultgård Ekwall AK, Grøn KL, Kapetanovic M, Faustini F, Tuompo R, Lorenzen T, Cagnotto G, Baecklund E, Hendricks O, Vedder D, Sokka-Isler T, Husmark T, Ljoså MA, Brodin E, Ellingsen T, Söderbergh A, Rizk M, Olsson ÅR, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Laurberg TB, Bakland G, Olsen IC, van Vollenhoven R; NORD-STAR study group. Hetland ML, et al. Among authors: heiberg ms. BMJ. 2020 Dec 2;371:m4328. doi: 10.1136/bmj.m4328. BMJ. 2020. PMID: 33268527 Free PMC article. Clinical Trial.
Association of rheumatoid factor, anti-citrullinated protein antibodies and shared epitope with clinical response to initial treatment in patients with early rheumatoid arthritis: data from a randomised controlled trial.
Lend K, Lampa J, Padyukov L, Hetland ML, Heiberg MS, Nordström DC, Nurmohamed MT, Rudin A, Østergaard M, Haavardsholm EA, Hørslev-Petersen K, Uhlig T, Sokka-Isler T, Gudbjornsson B, Grondal G, Frazzei G, Christiaans J, Wolbink G, Rispens T, Twisk JWR, van Vollenhoven RF. Lend K, et al. Among authors: heiberg ms. Ann Rheum Dis. 2024 Nov 14;83(12):1657-1665. doi: 10.1136/ard-2024-226024. Ann Rheum Dis. 2024. PMID: 39079894 Free PMC article. Clinical Trial.
Disease activity and treatment response in early rheumatoid arthritis: an exploratory metabolomic profiling in the NORD-STAR cohort.
Fatima T, Zhang Y, Vasileiadis GK, Rawshani A, van Vollenhoven R, Lampa J, Gudbjornsson B, Haavardsholm EA, Nordström D, Gröndal G, Hørslev-Petersen K, Lend K, Heiberg MS, Hetland ML, Nurmohamed M, Østergaard M, Uhlig T, Sokka-Isler T, Rudin A, Maglio C. Fatima T, et al. Among authors: heiberg ms. Arthritis Res Ther. 2025 Jul 26;27(1):156. doi: 10.1186/s13075-025-03616-6. Arthritis Res Ther. 2025. PMID: 40713837 Free PMC article. Clinical Trial.
Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm.
Hetland ML, Heiberg MS, Sokka-Isler T, Rudin A, Østergaard M, Haavardsholm E, Rutanen J, van Vollenhoven R, Grondal G, Ørnbjerg LM, Bøyesen P, Lampa J, Nurmohamed M, Gudbjornsson B, Uhlig T, Kononoff A, Lend K, Krabbe S, Olsen IC, Sexton J, Hørslev-Petersen K. Hetland ML, et al. Among authors: heiberg ms. Ann Rheum Dis. 2025 Jun;84(6):937-948. doi: 10.1016/j.ard.2025.03.002. Epub 2025 Apr 4. Ann Rheum Dis. 2025. PMID: 40188008 Free article.
Rheumatology congresses post COVID-19: we cannot regress.
Nordberg LB, Vikse J, Heiberg MS, Lillejordet E, Mæhlen MT, Kristianslund EK, Provan SA, Lillegraven S. Nordberg LB, et al. Among authors: heiberg ms. Lancet Rheumatol. 2023 Jul;5(7):e370-e371. doi: 10.1016/S2665-9913(23)00153-4. Epub 2023 Jun 2. Lancet Rheumatol. 2023. PMID: 37360002 Free PMC article. No abstract available.
Hand-dominant joint involvement pattern associates with favourable, and polyarthritis with unfavourable, treatment response to both csDMARDs and bDMARDs in early rheumatoid arthritis: a combined analysis of NORD-STAR and BeSt trials.
Nagafuchi Y, Maarseveen TD, Lend K, Rudin A, Gudbjornsson B, Nordström D, Haavardsholm EA, Gröndal G, Lampa J, Petersen KH, Heiberg MS, Hetland ML, Nurmohamed M, Østergaard M, van Vollenhoven R, Uhlig T, Sokka-Isler T, van den Akker EB, Huizinga TWJ, Bergstra SA, Knevel R. Nagafuchi Y, et al. Among authors: heiberg ms. Ann Rheum Dis. 2026 Jul;85(7):1218-1228. doi: 10.1016/j.ard.2026.02.005. Epub 2026 Mar 8. Ann Rheum Dis. 2026. PMID: 41796486 Free article.
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trial.
Lampa J, Nordström D, van Vollenhoven R, Lund Hetland M, Haavardsholm EA, Østergaard M, Rudin A, Heiberg MS, Nurmohamed M, Gudbjornsson B, Lend K, Hørslev-Petersen K, Sokka-Isler T, Gröndal G, Krabbe S, Lindqvist J, Gjertsson I, Glinatsi D, Kapetanovic M, Gentline C, Aga AB, Relas H, Lorenzen T, Cagnotto G, Back J, Hendricks O, Dijkshoorn B, Öberg K, Ljoså MK, Brodin E, Lindegaard HM, Söderbergh A, Rizk M, Kastbom A, Larsson P, Uhrenholt L, Just SA, Stevens DJ, Laurberg TB, Bakland G, Olsen IC, Sexton J, Uhlig T; NORD-STAR study group. Lampa J, et al. Among authors: heiberg ms. Lancet Rheumatol. 2026 Apr;8(4):e285-e294. doi: 10.1016/S2665-9913(26)00007-X. Lancet Rheumatol. 2026. PMID: 41881637 Clinical Trial.
Flare risk after oral glucocorticoid bridging with methotrexate or intra-articular bridging with triple therapy in early rheumatoid arthritis.
Lend K, Twisk JWR, Koopman FA, Rudin A, Hetland ML, Uhlig T, Nordström DC, Nurmohamed MT, Gudbjornsson B, Hørslev-Petersen K, Heiberg MS, Sokka-Isler T, Grondal G, Haavardsholm EA, Østergaard M, Lampa J, van Vollenhoven R. Lend K, et al. Among authors: heiberg ms. J Intern Med. 2026 Jun;299(6):741-753. doi: 10.1111/joim.70094. Epub 2026 Apr 6. J Intern Med. 2026. PMID: 41943506 Free PMC article.
[Bechterew disease--a consensus on diagnosis and treatment].
Dagfinrud H, Heiberg MS, Bakland G, Skomsvoll J, Kvien TK. Dagfinrud H, et al. Among authors: heiberg ms. Tidsskr Nor Laegeforen. 2007 Dec 13;127(24):3209-12. Tidsskr Nor Laegeforen. 2007. PMID: 18084362 Free article. Review. Norwegian.
28 results